tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

QuidelOrtho sees cost-savings of at least $50M in 2H24

Sees 2H and FY24 positive adjusted free cash flow to exceed 50% of adjusted EBITDA, including full year interest expense of $160M-$165M and CapEx of ~$170M, excluding reagent rentals.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1